Detection of matrix metalloproteinase -2 and -9 in various types of canine tumours

R PRAKASH KRUPAKARAN; T C BALAMURUGAN; A SHEEBA; R DURGA LAKSHMI; P PERUMAL

doi:10.56093/ijans.v86i9.61540

Authors

R PRAKASH KRUPAKARAN Veterinary College and Research Institute, Orathanadu, Tamil Nadu 614 625 India
T C BALAMURUGAN Veterinary College and Research Institute, Orathanadu, Tamil Nadu 614 625 India
A SHEEBA Veterinary College and Research Institute, Orathanadu, Tamil Nadu 614 625 India
R DURGA LAKSHMI Veterinary College and Research Institute, Orathanadu, Tamil Nadu 614 625 India
P PERUMAL Veterinary College and Research Institute, Orathanadu, Tamil Nadu 614 625 India

https://doi.org/10.56093/ijans.v86i9.61540

Keywords:

Canine tumours, Gelatin zymography, Matrix metalloproteinases

Abstract

A study was carried out to detect the matrix metalloproteinases (MMP-2 and MMP-9) in tissues by gelatin zymography in various types of canine tumours. Fresh canine tissue samples (24) up to 0.5 cm were collected at the time of biopsy, surgery and necropsy. Tissue samples were homogenated, filtered and subjected to gelatin zymography. All the tumours samples were proteolytically active as they fully degraded the gelatin. Except with minor variation, in all tumours, the major bands were observed at 220, 135 and 92 kDa of MMP-9 and 72 kDa of MMP-2 band. Among all the groups, histiocytoma and malignancy tumours showed 3–4 times higher intensity bands than the other groups. This clearly showed that the expression of the active form of MMP-2 and intensity of other bands depends upon the degree and stage of tumour. The latent form of 72 kDa MMP-2 was thicker than that of 92 kDa MMP-9 as in mammary gland tumour and fibroadenoma. In histiocytoma, the expression of MMP-2 and -9 was almost similar. It was concluded that MMP-2 and MMP-9 could be used as a diagnostic tool/marker to ascertain the degree and stage of particular tumour, whether it has reached to the stage of metastasis or not. Further study on the difference between serum MMP and tissue MMP could be carried out to assess the degree of metastasis.

Downloads

Download data is not yet available.

References

Aresu L, Giantin M, Morello E, Vascellari M, Castagnaro M, Lopparelli R, Zancanella V, Granato A, Garbisa S, Arico A, Bradaschia A, Mutinelli F and Dacasto M. 2011. Matrix metalloproteinases and their inhibitors in canine mammary tumours. BMC Veterinary Research 7:33. doi: 10.1186/1746- 6148–7–33 DOI: https://doi.org/10.1186/1746-6148-7-33

Benassi M S, Magagnoli G, Ponticelli F, Pazzaglia L, Zanella L, Gamberi G, Ragazzini P, Ferrari C, Mercuri M and Picci P. 2003. Tissue and serum loss of metalloproteinase inhibitors in high grade soft tissue sarcomas. Histology and Histopathology 18(4): 1035 – 40.

Creemers L B, Jansen I D, Docherty A J, Reynolds J J, Beertsen W, Everts V. 1998. Gelatinase A (MMP2) and cysteine proteinases are essential for the degradation of collagen in soft connective tissue. Matrix Biology 17(1): 35–46. DOI: https://doi.org/10.1016/S0945-053X(98)90123-8

Fang K C, Raymond W W, Lazarus S C and Caughey G H. 2015. Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase. Journal of Clinical Investigation 97(7):1589–96. DOI: https://doi.org/10.1172/JCI118583

Giancotti F G and Ruoslahti E. 1999. Integrin signaling. Science 285: 1028–32. DOI: https://doi.org/10.1126/science.285.5430.1028

Gilbert S J, Wotton P R, Tarlton J F, Duance V C and Bailey A J. 1997. Increase expression of promatrix metalloproteinase-9 and neutrophil elastase in canine dilated cardiomyopathy. Cardiovascular Research 34(2): 377–83. DOI: https://doi.org/10.1016/S0008-6363(97)00011-4

Heussen C and Dowdle E B. 1980. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Analytical Biochemistry 102(1): 196–202. DOI: https://doi.org/10.1016/0003-2697(80)90338-3

Hussaini I M, Trotter C, Zhao Y, Abdel-Fattah R, Amos S, Xiao A, Agi C U, Redpath G T, Fang Z, Leung G K, Lopes M B, Laws E R (Jr). 2007. Matrix metalloproteinase-9 is differentially expressed in non-functioning invasive and non- invasive pituitary adenomas and increases invasion in human pituitary adenoma cell line. The American Journal of Pathology 170(1): 356–65. DOI: https://doi.org/10.2353/ajpath.2007.060736

Laemmli U K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–85. DOI: https://doi.org/10.1038/227680a0

Loukopoulos P, Mungall B A, Straw R C, Thornton J R and Robinson W F. 2003. Matrix metalloproteinase-2 and -9 involvement in canine tumours. Veterinary Pathology 40(4): 382–94. DOI: https://doi.org/10.1354/vp.40-4-382

Maiti S K, Kumar D K M, Kumar S, Ravindran N A, Mathew D, Palakkara S, Muthalavi M A and Kumar N. 2014. Mammary gland tumours in male dogs: a hormonal and tumour marker study. Veterinarski Arhiv 84(5): 537–48.

Makowski G S and Ramsby M L. 1996. Calibrating gelatin zymograms with human gelatinase standards. Analytical Biochemistry 236(2): 353–56. DOI: https://doi.org/10.1006/abio.1996.0179

Nagase H. 1997. Activation mechanisms of matrix metalloproteinases. Journal of Biological Chemistry 378: 151– 60.

Nguyen M, Arkell J and Jackson C J. 2001. Human endothelial gelatinases and angiogenesis. International Journal of Biochemistry and Cell Biology 33(10): 960–70. DOI: https://doi.org/10.1016/S1357-2725(01)00007-3

Stetler-Stevenson W G.1990. Type IV collagenases in tumour invasion and metastasis. Cancer and Metastasis Reviews 9(4): 289–303. DOI: https://doi.org/10.1007/BF00049520

Woessner F J (Jr). 1995. Quantification of matrix metalloproteinases in tissue samples. Method in Enzymology 248: 510–28. DOI: https://doi.org/10.1016/0076-6879(95)48033-1

Yang H K, Jeong K C, Kim Y K and Jung S T. 2014. Role of matrix metalloproteinase (MMP) 2 and MMP-9 in soft tissue sarcoma. Clinics in Orthopedic Surgery 6(4): 443–54. DOI: https://doi.org/10.4055/cios.2014.6.4.443